Showing results (2601-2610 of 2,696) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|June 1, 2015
Design, recruitment, and microbiological considerations in human challenge studiesThomas C Darton, Christoph J Blohmke, Vasee S Moorthy, et al.
The Lancet. Infectious Diseases|August 11, 2022
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control studyPilar T V Florentino, Tristan Millington, Thiago Cerqueira-Silva, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
The Lancet. Infectious Diseases|May 23, 2020
Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trialHanqing He, Yamin Wang, Xuan Deng, et al.
The Lancet. Infectious Diseases|May 25, 2020
Reappraisal of the treatment duration of antibiotic regimens for acute uncomplicated cystitis in adult women: a systematic review and network meta-analysis of 61 randomised clinical trialsDo Kyung Kim, Jae Heon Kim, Joo Yong Lee, et al.
The Lancet. Infectious Diseases|April 30, 2021
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational studyCristina Menni, Kerstin Klaser, Anna May, et al.
The Lancet. Infectious Diseases|June 12, 2020
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive studyLuca Carsana, Aurelio Sonzogni, Ahmed Nasr, et al.
The Lancet. Infectious Diseases|June 12, 2020
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trialMichael G Ison, Simon Portsmouth, Yuki Yoshida, et al.
The Lancet. Infectious Diseases|June 17, 2020
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case seriesIvan Fan-Ngai Hung, Vincent Chi-Chung Cheng, Xin Li, et al.
The Lancet. Infectious Diseases|June 6, 2020
Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984-2018: an evaluation of Food and Drug Administration flexibilitiesJonathan J Darrow, Mehdi Najafzadeh, Kristina Stefanini, et al.
Pageof 270